In Part 3 of our Heme Path series, we break down the basics of immunohistochemistry (IHC)
Episode contents:
- What is immunohistochemistry?
- What are the pros and cons?
- How do we use this clinically?
****Have some time and want to make some extra money? Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FO ... Show More
Jan 21
Episode 145: Myeloma Series, Pt. 6 - First line treatment of Multiple Myeloma (2026)
This week, we begin our discussion about treatment of multiple myeloma, focusing on the first-line setting. Once again, a lot has changed in this space over the last few years, most notably the standards of care (now quadruplet regimens instead of triplet regimens!). We break dow ... Show More
40m 27s
Jan 7
Episode 144: Myeloma Series, Pt. 5 - Myeloma Risk Stratification and Response Criteria (2026)
This week, we introduce a new episode for our myeloma series, this time focusing on risk stratification and response criteria. The initial workup and surveillance labs are expansive, but all of the studies we do have a purpose. Many present-day studies also use “minimal residual ... Show More
29m 16s
Dec 30
Episode 143: Myeloma Series, Pt. 4 - Myeloma Pharmacology (2025)
We bring back our prior pharmacology discussion because it’s so incredibly important for the conversations that are on the horizon over the next few weeks. In this continuation of our myeloma series, we begin our discussion about treatment options for multiple myeloma, focusing f ... Show More
48m 42s
Oct 2024
ASRM Today: Equity, Access, and Innovation, Episode Nine: Reflections
<p>In this ASRM Today podcast episode, host Jeffrey Hayes reflects on the theme of Season 2, "equity, access, and innovation," in reproductive medicine. The season explores these ideas through personal, political, and cultural lenses, including an analysis of pop culture's influe ... Show More
4m 52s
Feb 2025
More Happier: The “More Happier” Debate, Do You Eat Before You Pay & Advice For Creative People
We review the great debate among listeners about whether our ungrammatical jokes about “More Happier” are fun—or annoying. We also discuss whether, as creative people, we expect our friends and family to read, watch, or listen to what we create. Plus we explore a silly question a ... Show More
25m 56s